[Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib].
Chen C, Xu N, Jiang X, Wu W, Zhou X, Liu L, Huang J, Yin C, Cao R, Liao L, Xu D, Zhang Y, Liu Q, Liu X.
Chen C, et al.
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Mar 30;39(3):364-368. doi: 10.12122/j.issn.1673-4254.2019.03.16.
Nan Fang Yi Ke Da Xue Xue Bao. 2019.
PMID: 31068313
Free PMC article.
Chinese.